Home › Funds › KVP Capital Advisors, LP › CABA
KVP Capital Advisors, LP position in CABA
CABALETTA BIO INC · Health Care
KVP Capital Advisors, LP reported holding 505,431 shares of CABA (CABALETTA BIO INC) in its Q2 2026 13F filing — a position valued at US$1.6M, representing 1.15% of its reported portfolio and ranking #31 among its reported holdings. KVP Capital Advisors, LP has disclosed CABA holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How KVP Capital Advisors, LP's CABA position evolved
KVP Capital Advisors, LP first disclosed a stake in CABA in Q4 2025 at 505,431 shares (US$1.1M). The position peaked in Q2 2026 at 505,431 shares, worth US$1.6M. Across 3 filings, KVP Capital Advisors, LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 505,431 shares valued at US$1.6M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 505.43K | $1.11M | New |
| Q1 2026 | 505.43K | $1.36M | Hold |
| Q2 2026 | 505.43K | $1.57M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CABA and 13F data
CABA (CABALETTA BIO INC) is a Health Care company. 38 other funds we track also report a position in CABA — the largest reported positions include Bain Capital Life Sciences Investors, LLC (US$53.6M), Cormorant Asset Management, LP (US$15.6M), Opaleye Management Inc. (US$12.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CABA
- Bain Capital Life Sciences Investors, LLC 17.24M sh · $53.62M · Q2 2026
- Cormorant Asset Management, LP 5.00M sh · $15.55M · Q2 2026
- Opaleye Management Inc. 3.86M sh · $12.02M · Q2 2026
- SUPERSTRING CAPITAL MANAGEMENT LP 1.28M sh · $3.48M · Q2 2026
- Stonepine Capital Management, LLC 917.10K sh · $2.85M · Q2 2026
- Blue Owl Capital Holdings LP 714.71K sh · $2.22M · Q2 2026
More on KVP Capital Advisors, LP
FAQ
How long has KVP Capital Advisors, LP held CABA?
KVP Capital Advisors, LP has disclosed CABA holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is KVP Capital Advisors, LP's current position in CABA?
As of Q2 2026, KVP Capital Advisors, LP holds 505.43K shares of CABA (CABALETTA BIO INC), valued at $1.57M, representing 1.15% of its reported portfolio and ranking #31.
Has KVP Capital Advisors, LP been buying or selling CABA?
In the latest 13F filing (Q2 2026), KVP Capital Advisors, LP held unchanged its position in CABA. The position peaked in Q2 2026 at 505.43K shares.
Which other funds hold CABA?
Other major institutional holders of CABA include Bain Capital Life Sciences Investors, LLC, Cormorant Asset Management, LP, Opaleye Management Inc., among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.